| Literature DB >> 27995493 |
Christoph Brochhausen1, Volker H Schmitt2, Andreas Mamilos3, Christine Schmitt4, Constanze N E Planck5,6, Taufiek K Rajab7, Helmut Hierlemann6,8, C James Kirkpatrick9.
Abstract
In preventing postoperative adhesion formation the optimal barrier material has still not been found. It is therefore imperative to assess the biocompatibility of potential barrier devices. Macrophages play a decisive role in the regulation of wound healing, tissue regeneration and foreign body reaction. Since the number of CD68-positive macrophages represents an important parameter within biomaterial testing, in the present study it was analysed whether a correlation exists between the total number of CD68-positive macrophages and the extent of fibrosis or inflammation in peritoneal adhesion prevention using biomaterials. After standardized peritoneal wounding, Wistar rats were treated with five adhesion barriers or remained untreated as a control. After 14 days, animals were sacrificed and the treated areas were evaluated histomorphologically and immunohistologically. A heterogeneous pattern of macrophage count in relation to fibrosis or inflammation was found. While some groups described a moderate macrophage infiltration without fibrosis, others showed similar numbers of macrophages, but accompanied by moderate fibrosis. Moreover, a minimal number of macrophages was associated with minimal fibrosis. Mild inflammation was seen both with minimal and moderate macrophage infiltration. Altogether, no correlation could be established between the tissue response and the count of CD68-positive macrophages. With a view to macrophage heterogeneity further studies are required to determine the different macrophage subpopulations and clarify the role of these in the tissue responses to barrier materials.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27995493 PMCID: PMC5167770 DOI: 10.1007/s10856-016-5821-3
Source DB: PubMed Journal: J Mater Sci Mater Med ISSN: 0957-4530 Impact factor: 3.896
The barrier materials used in this study
| Barrier | Manufacturer | Components |
|---|---|---|
| Adept® | ML Laboratories PLC, Hampshire, UK | Icodextrin, sodium chloride, sodium lactate, calcium chloride, magnesium chloride |
| Spraygel® | Confluent Surgical Inc.,Waltham, MA, USA | Polyethylene-glycol, water |
| Intercoat® | Ethicon, Somerville, NJ, USA | Carboxymethylcellulose, polyethylene oxide |
| Seprafilm® | Genzyme, Cambridge, MA, USA | Sodium hyaluronic acid with carboxymethylcellulose |
| SupraSeal® | PolyMedics Innovations GmbH, | Poly-DL-lactic acid, trimethylencarbonate Denkendorf, Germany and ε-caprolactone |
The evaluation score of the tissue response according to [30]
| Tissue response | Score | ||||
|---|---|---|---|---|---|
| None | Minimal | Mild | Moderate | Severe | |
| Polymorphonuclear granulocytes | 0 | Rare, 1–5/hpf* | 5–10/hpf | Heavy infiltrate | Packed |
| Lymphocytes/plasma cells | 0 | Rare, 1–5/hpf | 5–10/hpf | Heavy infiltrate | Packed |
| Foreign body-type multinucleated giant cells | 0 | Rare, 1–2/hpf | 3–5/hpf | Heavy infiltrate | Sheets |
| CD68-positive macrophages | 0 | Rare, 1–5/hpf | 5–10/hpf | Heavy infiltrate | Packed |
| Fibrosis | 0 | Narrow band | Moderate band | Broad band | Extensive band |
* hpf high power field (400× magnitude)
Semi-quantitative results of the control- and the Adept® group
| Barrier | Tissue response | Median | Q1/Q3 | Minimum | Maximum | |
|---|---|---|---|---|---|---|
| Control group | Granulocytes | Near the lesion | 3.5 | 2.4/5.1 | 2.1 | 12.0 |
| Afar from the lesion | 1.4 | 0.6/2.4 | 0.4 | 3.3 | ||
| Barrier value | 1.8 | 1.3/4.1 | 1.1 | 8.7 | ||
| Lymphocytes/plasma cells | Near the lesion | 0.2 | 0/1.1 | 0 | 1.6 | |
| Afar from the lesion | 0 | 0/0.1 | 0 | 0.1 | ||
| Barrier value | 0.2 | 0/1 | 0 | 8.7 | ||
| Macrophages | Near the lesion | 7.1 | 5.2/10.2 | 2.9 | 36.7 | |
| Afar from the lesion | 1.9 | 0.6/2.4 | 0 | 2.7 | ||
| Barrier value | 5.2 | 3/10.2 | 2.3 | 34.3 | ||
| Foreign body-type multinucleated | Near the lesion | 0 | 0/0 | 0 | 0.3 | |
| giant cells | Afar from the lesion | 0 | 0/0 | 0 | 0 | |
| Barrier value | 0 | 0/0 | 0 | 0.3 | ||
| Band of fibrosis | Near the lesion | Moderate | Moderate/broad | Narrow | Broad | |
| Afar from the lesion | Narrow | Narrow/moderate | Narrow | Moderate | ||
| Barrier value | Narrow | None/moderate | None | Moderate | ||
| Adept® group | Granulocytes | Near the lesion | 4 | 3.8/6.7 | 3.7 | 8.7 |
| Afar from the lesion | 1.7 | 1.3/2.4 | 0.6 | 3.7 | ||
| Barrier value | 2.5 | 1.8/3 | 1.6 | 8.1 | ||
| Lymphocytes/plasma cells | Near the lesion | 0.4 | 0.1/0.7 | 0 | 3.3 | |
| Afar from the lesion | 0.1 | 0/0.2 | 0 | 0.3 | ||
| Barrier value | 0.3 | −0.1/0.7 | −0.2 | 3.3 | ||
| Macrophages | Near the lesion | 5.4 | 1.3/7.4 | 0.5 | 12.8 | |
| Afar from the lesion | 1.4 | 0.8/4.5 | 0.5 | 5 | ||
| Barrier value | 3.2 | 0.8/4.6 | −0.9 | 7.8 | ||
| Foreign body-type multinucleated | Near the lesion | 0.6 | 0.3/1.4 | 0.2 | 2.4 | |
| giant cells | Afar from the lesion | 0.1 | 0/0.1 | 0 | 0.1 | |
| Barrier value | 0.5 | 0.3/1.3 | 0.1 | 2.3 | ||
| Band of fibrosis | Near the lesion | Moderate | Moderate/broad | Moderate | Extensive | |
| Afar from the lesion | Narrow | Narrow/narrow | Narrow | Moderate | ||
| Barrier value | Narrow | Narrow/moderate | Narrow | Broad | ||
Semi-quantitative results of the Seprafilm-® and the SupraSeal® group
| Barrier | Tissue response | Median | Q1 | Minimum | Maximum | |
|---|---|---|---|---|---|---|
| Seprafilm® group | Granulocytes | Near the lesion | 1.6 | 1/3.9 | 0.9 | 5.1 |
| Afar from the lesion | 0.5 | 0.4/0.8 | 0.3 | 2.5 | ||
| Barrier value | 1.1 | 0.5/2.2 | 0.5 | 4.3 | ||
| Lymphocytes/plasma cells | Near the lesion | 0.2 | 0.1/0.2 | 0 | 1.3 | |
| Afar from the lesion | 0 | 0/0.3 | 0 | 0.4 | ||
| Barrier value | 0.2 | 0/0.2 | −0.1 | 0.9 | ||
| Macrophages | Near the lesion | 23.8 | 13.1/24.8 | 1 | 48.1 | |
| Afar from the lesion | 7 | 2.6/19.6 | 1.8 | 33.6 | ||
| Barrier value | 10.5 | 5.2/14.5 | −0.8 | 18.9 | ||
| Foreign body-type multinucleated | Near the lesion | 0 | 0/0 | 0 | 0.1 | |
| giant cells | Afar from the lesion | 0 | 0/0 | 0 | 0 | |
| Barrier value | 0 | 0/0 | 0 | 0.1 | ||
| Band of fibrosis | Near the lesion | Moderate | Narrow/broad | Narrow | Broad | |
| Afar from the lesion | Narrow | Narrow/narrow | Narrow | Broad | ||
| Barrier value | Narrow | None/narrow | None | Moderate | ||
| SupraSeal® group | Granulocytes | Near the lesion | 23.2 | 3.8/30.1 | 0.6 | 62.9 |
| Afar from the lesion | 0.7 | 0.6/1.7 | 0.4 | 1.9 | ||
| Barrier value | 21.5 | 2.7/29.5 | 0 | 61 | ||
| Lymphocytes/plasma cells | Near the lesion | 0 | 0/0.2 | 0 | 0.4 | |
| Afar from the lesion | 0 | 0/0.1 | 0 | 0.9 | ||
| Barrier value | 0 | 0/0.1 | −0.5 | 0.1 | ||
| Macrophages | Near the lesion | 36.6 | 22.5/47.2 | 11.9 | 54.3 | |
| Afar from the lesion | 4.3 | 2/14.2 | 1.3 | 16.9 | ||
| Barrier value | 32.4 | 20.5/37.4 | 7.6 | 40.1 | ||
| Foreign body-type multinucleated | Near the lesion | 0.5 | 0.3/0.8 | 0 | 2.1 | |
| giant cells | Afar from the lesion | 0 | 0/0.1 | 0 | 0.2 | |
| Barrier value | 0.5 | 0.3/0.7 | −0.1 | 2 | ||
| Band of Fibrosis | Near the lesion | Narrow | Narrow/narrow | Narrow | Broad | |
| Afar from the lesion | Narrow | Narrow/narrow | Narrow | Moderate | ||
| Barrier value | None | None/none | None | Narrow | ||
Fig. 1Comparison of the tissue response of the (a) control group and (b) animals treated with Adept® regarding the count of cells and degree of fibrosis using boxplots. Minimal and mild macrophage infiltrations were both accompanied with a minimal inflammatory response in these groups. Also, in these animals minimal fibrosis was accompanied with mild (control group) and minimal (Adept®) infiltration of macrophages
Fig. 3Boxplots showing the tissue response to (a) Seprafilm® and (b) SupraSeal®. In these groups moderate macrophage infiltration was seen with both a minimal (Seprafilm®) and a moderate inflammatory response (SupraSeal®). No fibrosis was seen with moderate macrophage infiltration in the animals treated with SupraSeal® whereas in the Seprafilm® group minimal fibrosis was accompanied with a moderate infiltration of macrophages. Taken the results of Figs. 1–3 together, the count of macrophages did not go along with any type of tissue response
Fig. 4(a) The control group shows a flat mesothelial cell layer (arrows) and blood vessels (v) (HE ×200) as well as (b) some macrophages (arrows) (CD68-staining ×200). (c) In the Adept® group, flat mesothelium (arrows)-covered connective tissue (*) with blood vessels (v) and subjacent muscle (m) are seen (HE ×200). (d) Some macrophages (arrows) were observed within the submesothelium (CD68 staining ×400). (e) Intercoat® revealed flat mesothelial cells (arrows) on top of connective tissue with blood vessels (v) (HE ×400) and (f) a considerable infiltration with (arrows) macrophages (CD68 staining ×200)
Fig. 2The tissue response to (a) the Intercoat® and (b) the Spraygel® group regarding polymorphonuclear granulocytes, lymphocytes/plasma cells, foreign body giant cells, fibrosis and macrophages. Here, moderate macrophage infiltration was accompanied with a minimal inflammatory response in the animals treated with Intercoat® and mild inflammation in the Spraygel® group. Regarding fibrosis, both a moderate extent (Intercoat®) and no fibrosis (Spraygel®) were seen with moderate macrophage infiltration
Semi-quantitative results of the Intercoat-® and the Spraygel® group
| Barrier | Tissue response | Median | Q1/Q3 | Minimum | Maximum | |
|---|---|---|---|---|---|---|
| Intercoat® group | Granulocytes | Near the lesion | 1.4 | 1/2.6 | 0.5 | 3.2 |
| Afar from the lesion | 0.4 | 0.2/0.5 | 0.1 | 1.2 | ||
| Barrier value | 1.1 | 0.6/1.4 | 0.4 | 2.7 | ||
| Lymphocytes/plasma cells | Near the lesion | 0.3 | 0.2/1 | 0.2 | 1.6 | |
| Afar from the lesion | 0.1 | 0.1/0.7 | 0 | 2.7 | ||
| Barrier value | 0.1 | −0.2/0.3 | −1.7 | 0.9 | ||
| Macrophages | Near the lesion | 44.9 | 28/57.5 | 21.7 | 80.8 | |
| Afar from the lesion | 12.2 | 1.2/28.1 | 0.8 | 50.7 | ||
| Barrier value | 28.8 | 20.5/35.2 | 17.7 | 42.8 | ||
| Foreign body-type multinucleated | Near the lesion | 0 | 0/0 | 0 | 0 | |
| giant cells | Afar from the lesion | 0 | 0/0 | 0 | 0 | |
| Barrier value | 0 | 0/0 | 0 | 0 | ||
| Band of fibrosis | Near the lesion | Broad | Narrow/extensive | Narrow | Extensive | |
| Afar from the lesion | Narrow | Narrow/narrow | Narrow | Moderate | ||
| Barrier value | Moderate | None/moderate | None | Broad | ||
| Spraygel® group | Granulocytes | Near the lesion | 9.1 | 4.6/29.4 | 4.4 | 32.2 |
| Afar from the lesion | 1.7 | 0.8/2.1 | 0.5 | 3.1 | ||
| Barrier value | 7 | 3.9/28.6 | 2.9 | 30.5 | ||
| Lymphocytes/plasma cells | Near the lesion | 0.2 | 0/0.4 | 0 | 1.7 | |
| Afar from the lesion | 0 | 0/0.1 | 0 | 0.1 | ||
| Barrier value | 0.1 | 0/0.4 | 0 | 1.6 | ||
| Macrophages | Near the lesion | 24.2 | 7.4/29.8 | 6.8 | 41.6 | |
| Afar from the lesion | 7.5 | 2.5/9.3 | 1.1 | 18.3 | ||
| Barrier value | 10.3 | 4.9/20.5 | 1.9 | 34.1 | ||
| Foreign body-type multinucleated | Near the lesion | 0.1 | 0/0.2 | 0 | 0.3 | |
| giant cells | Afar from the lesion | 0 | 0/0 | 0 | 0 | |
| Barrier value | 0.1 | 0/0.2 | 0 | 0.3 | ||
| Band of fibrosis | Near the lesion | Moderate | Narrow/broad | Narrow | Extensive | |
| Afar from the lesion | Narrow | Narrow/moderate | Narrow | Moderate | ||
| Barrier value | None | None/moderate | None | Broad | ||
Fig. 5(a) In the Spraygel® group submesothelial abscesses (*) were present (HE ×20) as well as (b) a moderate infiltration with macrophages (CD68 staining ×200). (c) Seprafilm® revealed minimal amounts of granulocytes (arrows) and lymphocytes (*) (HE ×200) as well as (d) moderate infiltration with macrophages (CD68 staining, ×200). (e) In the SupraSeal® group, a dense layer of flat mesothelial cells (arrows) covered connective tissue containing blood vessels (v) (HE ×200). (f) There was a high presence of macrophages (arrows) adjacent to the barrier (CD68 staining, ×100)
The tissue response to the barrier types according to [30]
| Barrier | Inflammation | Foreign body reaction | Extent of fibrosis | CD68-positive macrophages | |
|---|---|---|---|---|---|
| Polymorphonuclear granulocytes | Lymphocytes/plasma cells | ||||
| Control | Minimal | None | None | Narrow band | Mild |
| Adept® | Minimal | None | None | Narrow band | Minimal |
| Intercoat® | Minimal | None | None | Moderate band | Moderate–severe |
| Spraygel® | Mild | None | None | No fibrosis | Moderate |
| Seprafilm® | Minimal | None | None | Narrow band | Moderate |
| SupraSeal® | Moderate | None | None | No fibrosis | Moderate–severe |
Results of the correlation analysis performed via Pearson product-moment correlation coefficient: Significant correlations were seen regarding the foreign body reaction and the amount of macrophages in the Adept® group (r > 0.6, p < 0.05)
| Barrier group | Granulocytes | Lymphocytes/plasma cells | Foreign body giant cells | Extent of fibrosis | |
|---|---|---|---|---|---|
| Control group | Pearson-Corr. | −0.179 | −0.390 | 0.040 | 0.165 |
|
| P | 0.702 | 0.387 | 0.932 | 0.724 |
| Adept® | Pearson-Corr. | 0.123 | 0.228 | 0.839 | 0.300 |
|
| P | 0.793 | 0.624 | 0.018 | 0.514 |
| Intercoat® | Pearson-Corr. | 0.727 | 0.209 | 0.246 | |
|
| P | 0.064 | 0.653 | 0.595 | |
| Spraygel® | Pearson-Corr. | −0.402 | 0.669 | −0.311 | −0.023 |
|
| P | 0.371 | 0.101 | 0.497 | 0.961 |
| Seprafilm® | Pearson-Corr. | −0.403 | −0.217 | −0.711 | 0.367 |
|
| P | 0.370 | 0.640 | 0.073 | 0.418 |
| SupraSeal® | Pearson-Corr. | 0.491 | 0.712 | 0.324 | −0.833 |
|
| P | 0.263 | 0.073 | 0.478 | 0.020 |
| All samples | Pearson-Corr. | 0.264 | −0.167 | 0.017 | −0.101 |
|
| P | 0.091 | 0.290 | 0.917 | 0.526 |
Also, a significant negative correlation between macrophage infiltration and the amount of fibrosis was found in the SupraSeal® group (r < −0.6, p < 0.05). Statistical trends were seen between the amount of macrophages and the infiltration of granulocytes (positive correlation in the Intercoat® group, r > 0.6, p < 0.1 and no correlation regarding all samples, −0.6 < r < 0.6, p < 0.1) as well as between the presence of macrophages and the lymphocytic infiltration in the SupraSeal® group (r > 0.6, p < 0.1). Further, a trend to negative correlation between macrophages and the amount of foreign body giant cells was seen in the Seprafilm® group (r < −0.6, p < 0.1). Although not all results are significant, mainly due to a low number of animals per group, the results are interesting since they show that there is no clear correlation between the amount of macrophages and the biocompatibility of barrier materials regarding inflammation, foreign body reaction or fibrosis